Big Sioux Wealth Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
Big Sioux Wealth Management's INO Position: Q3 2026 in Review
Big Sioux Wealth Management sold out of Inovio Pharmaceuticals (INO) in Q3 2026, closing a stake of 11 shares — an estimated $12 sold.
Big Sioux Wealth Management first reported a position in INO in Q4 2025 and held it in 3 quarters. The position peaked at $19 in Q1 2026. 112 funds tracked by Wall St. Rank hold INO as of Q3 2026.
- Big Sioux Wealth Management reported no remaining Inovio Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Big Sioux Wealth Management sold 11 Inovio Pharmaceuticals shares in Q3 2026, an estimated $12.
- Big Sioux Wealth Management first reported a position in Inovio Pharmaceuticals in Q4 2025 and held it in 3 quarters.
- Big Sioux Wealth Management's Inovio Pharmaceuticals position peaked at $19 in Q1 2026.
- 112 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.
Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.